期刊文献+

72例膀胱移行细胞癌中Fas和FasL的表达 被引量:8

The expressions of Fas and FasL in 72 cases with transitional cell cancer of bladder
暂未订购
导出
摘要 目的 :探讨细胞凋亡基因Fas和FasL在膀胱癌发病中作用及与肿瘤生物学行为和预后之间关系。方法 :应用免疫组化方法检测 16例正常膀胱粘膜和 72例膀胱移行细胞癌标本中Fas和FasL表达。结果 :膀胱癌中Fas和FasL表达均显著低于正常膀胱粘膜中表达 ;Fas表达与肿瘤分级、分期和复发之间均密切相关 ,但FasL表达与三者之间均无相关性。结论 :Fas和FasL系统异常可能是膀胱癌发生发展过程中免疫逃避的重要因素 ; Objective:To investigate the roles of pro apoptosis genes Fas and FasL in the pathogenesis of transitional cell cancer of bladder and their relationships with tumor biological behaviors and prognosis. Methods: The immunohistochemistry technique was applied to examine the expression of Fas and FasL in 16 normal bladder mucosa and 72 specimens of transitional cell cancer of bladder. Results:The expressions of Fas and FasL in bladder cancer were significantly lower than those in normal mucosa. The expression of Fas was closely associated with tumor grade, stage and recurrence, while there was no relationship being found for the FasL expression. Conclusions: Fas and FasL system play an important role of immune privilege in the development and progression of bladder cancer; Fas may be a predictor for biological behaviors and prognosis of bladder cancer.
机构地区 解放军第
出处 《癌症》 SCIE CAS CSCD 北大核心 2000年第2期156-158,共3页 Chinese Journal of Cancer
关键词 膀胱肿瘤 FAS 细胞凋亡 移行细胞癌 FASL Bladder neoplasm Fas Apoptosis
  • 相关文献

参考文献2

二级参考文献1

  • 1朱幼芙,J Gastroenterol Hepatol,1997年,12卷,121页

共引文献11

同被引文献62

  • 1苗旭东,杨迪生,叶招明,徐荣臻,张桂娣.细菌氧化还原蛋白azurin诱导U2OS细胞凋亡过程中caspase-3的活化[J].中国病理生理杂志,2004,20(9):1650-1653. 被引量:7
  • 2叶招明,苗旭东,杨迪生,徐荣臻,黄新,葛芬芬.细菌氧化还原蛋白azurin选择性诱导人骨肉瘤U2OS细胞凋亡[J].癌症,2005,24(3):298-304. 被引量:5
  • 3李印,马军,郑世营,葛锦峰,赵军.食管鳞癌及不典型增生组织Fas/FasL的表达[J].胃肠病学和肝病学杂志,2005,14(6):590-593. 被引量:3
  • 4Nagata S,and Golstein P. The Fas death factor[J]. Science, 1995,267 (5203) : 1449.
  • 5Park JR, Hockenbery DM. bcl-2, a novel regulator of apoptosis[J]. J Cell Biochem, 1996,60(1) : 12.
  • 6Leithauser F, Dhein J, Mechtersheimer G, et al. Consitutire and induced expression of APO-1 ,a new member of the new grow factor/tumor necrosis receptor superfamily,in normal and neoplastic cell [J]. Lab Invest, 1993,69(4):415.
  • 7Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family[J]. Cell, 1993,75(6) : 1169.
  • 8Montel AH, Bochan MR, Hobbs JA, et al. Fas involvement in cytotoxicity mediated by human NK cells[J].Cell Immunol, 1995,166(2) :236.
  • 9Lee SH, Lee JY,Park WS, et al. Transitional cell carcinama expresses high levels of Fas ligand in vivo[J]. BJU International, 1999,83 (6) .- 698.
  • 10Seino K, Kayagaki N, Fukao K, et al. Rejection of Fas ligand-expressing grafts[J]. Tansplatation Proceedings,1997,29(1--2) : 1092.

引证文献8

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部